Dr. Maged Azer, MD

Dr. Azer practices at Pavilion Surgery Center in Orange, California.

Dr. Azer's NPI, 1992730709, was assigned on July 11, 2006. Dr. Azer graduated from Cairo University School of Medicine in 1987. Dr. Azer holds California license A53477.

Dr. Azer's primary practice is Pavilion Surgery Center, at 1140 West La Veta Ave, Suite 300, Orange, CA 92868. The practice phone is (949) 390-9656.

Dr. Azer's primary practice is Pavilion Surgery Center in Orange, California. Dr. Azer is also affiliated with Providence St. Joseph Hospital Orange. The medical group on file is Orange County Heart Institute. Dmand AI also links Dr. Azer to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azer practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Azer's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Azer is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Azer is licensed in California.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and coronary artery disease among the conditions Dr. Azer treats.

CMS data shows 5,732 Medicare services from Dr. Azer across 28 procedure codes in 2024, for 964 Medicare patients. Medicare paid $1,063,728 for them.

CMS counts 964 Medicare patients who saw Dr. Azer in 2024. The largest group is 75 to 84, with 400 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azer's median patient age at 74, with 50% women.

In 2024, Dr. Azer wrote 4,866 Medicare Part D claims for 582 patients. 78% of them were for generic drugs. CMS names the drug for 4,662 of them, across 52 drugs with 11 or more claims each, at $967,492 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Azer for performance year 2024, reported individually. Dr. Azer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Azer, published from 2013 to 2015. The most frequent topics are Double-Blind Method, Heart Failure and Natriuretic Peptide, Brain. Dr. Azer's most frequent co-authors are Denise D. Barnard, MD, Geir Paul Frivold, MD and Barry Greenberg, MD.

CMS Open Payments shows 80 general payments to Dr. Azer from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $360.

Dmand AI lists 2 awards for Dr. Azer, most recently CMS Stage 1 2012 in 2012.

Dr. Azer graduated from Cairo University School of Medicine in 1987. Dr. Azer is a member of ACC.

Dr. Azer is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.